Non-nucleoside reverse transcriptase inhibitor outcomes among combination antiretroviral therapy-treated adults in Botswana.
about
Outcomes for efavirenz versus nevirapine-containing regimens for treatment of HIV-1 infection: a systematic review and meta-analysisEfavirenz-Based Regimens in Antiretroviral-Naive HIV-Infected Patients: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsEfavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals48-week efficacy and safety of dolutegravir relative to commonly used third agents in treatment-naive HIV-1-infected patients: a systematic review and network meta-analysis.Contemporary review of drug-induced pancreatitis: A different perspective.Lack of effect from a previous single dose of nevirapine on virologic and immunologic responses after 6 months of antiretroviral regimens containing either efavirenz or lopinavir-ritonavir.Nevirapine-based regimens in HIV-infected antiretroviral-naive patients: systematic review and meta-analysis of randomized controlled trials.An assessment of adverse drug reactions among HIV positive patients receiving antiretroviral treatment in South Africa.Non-AIDS-defining events among HIV-1-infected adults receiving combination antiretroviral therapy in resource-replete versus resource-limited urban settingHIV-Antiretroviral Therapy Induced Liver, Gastrointestinal, and Pancreatic Injury.Comparative effectiveness of efavirenz-based antiretroviral regimens in resource-limited settingsRates and predictors of failure of first-line antiretroviral therapy and switch to second-line ART in South AfricaRisk factors for symptomatic hyperlactatemia and lactic acidosis among combination antiretroviral therapy-treated adults in Botswana: results from a clinical trial.Effect modification by sex and baseline CD4+ cell count among adults receiving combination antiretroviral therapy in Botswana: results from a clinical trial.Validation of A Point-of-Care Lactate Device For Screening At-Risk Adults Receiving Combination Antiretroviral Therapy In BotswanaPersistently elevated serum interleukin-6 predicts mortality among adults receiving combination antiretroviral therapy in Botswana: results from a clinical trial.Use of first line antiretroviral therapy from a free ART programme clinic in Pune, India - a preliminary report.A Randomized Switch From Nevirapine-Based Antiretroviral Therapy to Single Tablet Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate in Virologically Suppressed Human Immunodeficiency Virus-1-Infected Rwandans.Projecting the clinical benefits and risks of using efavirenz-containing antiretroviral therapy regimens in women of childbearing age.Assessing adherence to antiretroviral therapy in randomized HIV clinical trials: a review of currently used methods.Targeted maximum likelihood estimation of effect modification parameters in survival analysis.
P2860
Q27021762-7E6927F8-B38A-4E6E-96B4-C1E09EECD97DQ28081266-80D88119-FBD8-4847-8BF0-EC4FE81943C5Q30240127-BA9B4D87-81C2-4B6F-A1A3-FEBF9814E0E9Q34134900-EE4B8EBA-0CBA-4415-B1FF-FBB2A8ACD84DQ34508837-EB398EE8-DEBC-4657-B466-BC3DB3EC2BB1Q34679736-78A125DA-53D7-4E1E-A07F-B2DA2BABB919Q35014739-C93BAD7B-3A8D-4121-9083-CCB63430EB2CQ35147717-99AFA69F-DE86-40D0-861F-6F2524429395Q35282729-1E19E9AC-ADD9-4D8C-A191-E66D383F410BQ35852627-578F2262-24BA-42EC-B6AC-FCDE7E6239F1Q36031230-E9168336-63D0-47D9-87F1-F5178A67DADBQ36083869-179FB14A-A522-40DA-8378-F8220552E529Q36102516-61878B5E-18D8-4294-A2A7-32D6AA9A228AQ36177514-78F4F636-448E-47A6-9FE9-E7D025148BAAQ36329990-CC6467E4-CA87-4DE9-A844-506252FEC11DQ36937881-AC71AA79-D126-425B-9B8B-5F9F5A45D642Q37073154-7ADBED61-676E-4EF1-AF2A-44A91D7476AAQ37305526-08F2B797-5584-467A-ABBF-443B0FAEA7CEQ37326983-564320B6-6B7E-4F20-94CE-A5789F8585A4Q38086335-DB7706E3-5BEC-4B42-B235-C20B99329455Q51607965-78EF97AB-4703-4FA2-AD33-F97C8DBA9C37
P2860
Non-nucleoside reverse transcriptase inhibitor outcomes among combination antiretroviral therapy-treated adults in Botswana.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Non-nucleoside reverse transcr ...... py-treated adults in Botswana.
@ast
Non-nucleoside reverse transcr ...... py-treated adults in Botswana.
@en
Non-nucleoside reverse transcr ...... py-treated adults in Botswana.
@nl
type
label
Non-nucleoside reverse transcr ...... py-treated adults in Botswana.
@ast
Non-nucleoside reverse transcr ...... py-treated adults in Botswana.
@en
Non-nucleoside reverse transcr ...... py-treated adults in Botswana.
@nl
prefLabel
Non-nucleoside reverse transcr ...... py-treated adults in Botswana.
@ast
Non-nucleoside reverse transcr ...... py-treated adults in Botswana.
@en
Non-nucleoside reverse transcr ...... py-treated adults in Botswana.
@nl
P2093
P2860
P50
P1433
P1476
Non-nucleoside reverse transcr ...... py-treated adults in Botswana.
@en
P2093
Ann Muir Thomas
C William Wester
Hermann Bussmann
Joseph M Makhema
Richard G Marlink
Tendani Gaolathe
Victor deGruttola
P2860
P304
P356
10.1097/01.AIDS.0000366080.91192.55
P407
P478
24 Suppl 1
P577
2010-01-01T00:00:00Z